Asymptomatic Cerebrovascular Lesions Detected by Magnetic Resonance Imaging in Patients with Systemic Lupus Erythematosus Lacking a History of Neuropsychiatric Events

Internal Medicine

Volumn 38, Issue 10, 1999, Pages 785-795

  Nomura, Kumiko ^a   Yamano, Shigeru ^a   Ikeda, Yukiko ^a   Yamada, Hideki ^a   Fujimoto, Takashi ^a   Minami, Shigetoshi ^a   Fukui, Rie ^a   Takaoka, Minoru ^a   Yamamoto, Yuta ^a   Dohi, Kazuhiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti cardiolipin antibodies (aCL); Carotid ultrasonography; Single photon emission computed tomography (SPECT); SLE disease activity index (SLEDAI); Vasculitis

Indexed keywords

CARDIOLIPIN ANTIBODY; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BRAIN; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CLASSIFICATION; COMMON CAROTID ARTERY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREVALENCE; RISK FACTOR; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; BRAIN; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033211027     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.785     Document Type: Article

References (62)

1. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 21: 55-64, 1991.
2. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus: patient characteristics associated with poorer outcomes. Arthritis Rheum 38: 274-283, 1995.
3. Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 20: 583-591, 1989.
4. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 31: 159-166, 1988.
5. Ameno M, Fujimoto T, Kuga Y, Fujii K, Dohi K, Mano y. A case of systemic lupus erythematosus with various neurological disorders related to anti-phospholipid antibodies (in Japanese with English abstract). J Nara Med Ass 48: 5-10, 1997.
6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and The Committee on prognosis studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35: 630-640, 1992.
7. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erytematosus. Arthritis Rheum 25: 1271-1277, 1982.
8. Ohsawa T, Matsubara E, Shoji M, Okamoto K, Hirai S. Asymptomatic cerebral infarcion examined by magnetic resonance imaging (MRI). Neurol Med (Tokyo) 40: 176-180, 1994.
9. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74: 1399-1406, 1986.
10. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 81: 33-40, 1990.
11. Pipberger HV, Arzbaecher RC, Berson AS, et al. Recommendations for standardization of leads and specifications for instruments in electrocardiography and vectorcardiography: report of the Committee on Electrocardiography, American Heart Association. Circulation I-1-I (suppl I): 31, 1975.
12. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Mesurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 62: 738-745, 1985.
13. Jacob C, Jay B, Richard JG. Renal disease: classification and atlas of glomerular diseases, second edition. IGAKU-SHOIN New York · Tokyo Chapter 7: 151-179, 1995.
14. Kobayashi S, Okada K, Yamashita K. Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors. Stroke 22: 1379-1383, 1991.
15. Jarek MJ, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 37: 1609-1613, 1994.
16. Stimmler MM, Coletti PM, Quismorio FP Jr. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 22: 335-349, 1993.
17. Bell CL, Partington C, Robinns M, Graziano F, Turski P, Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 34: 432-441, 1991.
18. Stoppe G, Wildhagen K, Seidel JW, et al. Positron emission tomography in neuropsyciatric lupus erythematosus. Neurology 40: 304-308, 1990.
19. Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 48: 1014-1022, 1989.
20. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. AJR Am J Roentgenol 144: 1027-1031, 1985.
21. Jacobs L, Kinkel PR, Costello PB, Alukal MK, Kinkel WR, Green FA. Central nervous system lupus erythematosus; the value of magnetic resonance imaging. J Rheumatol 15: 601-606, 1988.
22. Vermess M, Bernstein RM, Bydder GM, Steiner RE, Young IR, Hughes GR. Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus. J Comput Assist Tomogr 7: 461-467, 1983.
23. Kinkel WR, Green FA, Kinkel PR, Jacobs L. Magnetic resonance imaging in patients with systemic lupus erythematosus and sings of central nervous system involvement. Neurology 35 (suppl. 1): 216, 1985.
24. Miller DH, Ormerod IEC, Gibson A, du Boulay EPGH, Rudge P, McDonald WI. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 29: 226-231, 1987.
25. Griffey RH, Brown MS, Bankhurst AD, Sibbitt RR, Sibbitt WL Jr. Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Arthritis Rheum 33: 827-833, 1990.
26. Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol 21: 87-90, 1994.
27. Sewell KL, Livneh A, Aranow CB, Grayzel AI. Magnetic resonance imaging versus computed tomographic scanning in neuropsyciatric systemic lupus erythematosus. Am J Med 86: 625-626, 1989.
28. Kertesz A, Black SF, Tokar G, Benke T, Carr T, Nicholson L. Periventricular and subcortical hyperintensities on magnetic resonance imaging. 'Rims, caps and unidentified bright objects'. Arch Neurol 45: 404-408, 1988.
29. Fazekas F, Kleinert R, Offenbacher H, et al. The morphologic correlate of incidental punctate white-matter hyperintensities on MR images. AJNR Am J Neuroradiol 12: 915-921, 1991.
30. Gonzalez-Crespo MR, Blanco FJ, Ramos A, et al. Magnetic resonance imaging of the brain in systemic lupus erythemalosus. Br J Rheumatol 34: 1055-1060, 1995.
31. Rubbert T, Marienhagen J, Pirner K, et al. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 36: 1253-1262, 1993.
32. Baker MR, West SG, Rak KM. Clinical utility of brain magnetic resonance imaging (MRI) in systemic lupus erythematosus (SLE) patients with and without a history of neuropsychiatric lupus erythematosus (NPLE). Arthritis Rheum 34: S64, 1991 (Abstract).
33. Nossent JC, Hovestadt A, Schonfeld DHW, Swaak AJG. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 34: 1397-1403, 1991.
34. Rogers MP, Waterhouse E, Nagel JS, et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study. Lupus 1: 215-219, 1992.
35. Szer IS, Miller JH, Rawlings D, Shaham B, Bernstein B. Cerebral perfusion abnormalities in children with central nervous system manifestation of lupus detected by single photon emission computed tomography. J Rheumatol 20: 2143-2148, 1993.
36. Kovacs JAJ, Urowitz MB, Gladman DD, Zeman R. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol 22: 1247-1253, 1995.
37. Colamussi P, Trotta F, Ricci R, et al. Brain perfusion SPECT and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations. Nucl Med Commun 18: 269-273, 1997.
38. Falcini F, De Cristofaro MTR, Ermini M, et al. Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. J Rheumatol 25: 583-588, 1998.
39. Kodama K, Okada S, Hino T, et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psychiatry 58: 307-311, 1995.
40. Gladman DD, Goldsmith CH, Urowits MB, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 21: 1468-1471, 1994.
41. Taccari E, Sili Scavalli A, Spadaro A, et al. Magnetic resonance imaging (MRI) of the brain in SLE: ECLAM and SLEDAI correlations. Clin Exp Rheumatol 12: 23-28, 1994.
42. Vern BA, Butler M. Transient thalamic hypodensity in lupus erythematosus with generalized seizures. Neurology 33: 1081-1083, 1983.
43. Sibbitt WL, Sibbitt RR, Griffey RH, Ecckel C, Bankhurst AD. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsyciatric disease in systemic lupus erythematosus. Ann Rheum Dis 48: 1014-1022, 1989.
44. Tsokos GC, Tsokos M, le Riche NGH, Klippel JH. A clinical and pathologic study of cerebrovascular disease in patients with systemic lupus erythematosus. Semin Arthritis Rheum 16: 70-78, 1986.
45. Kitagawa Y, Gotoh F, Koto A, Okayasu H. Stroke in sytemic lupus erythematosus. Stroke 21: 1533-1539, 1990 (published erratum appears in Stroke 22: 417, 1991).
46. Fairfax AJ, Lambert CD, Leatham A. Systemic embolism in chronic sinoatrial disorder. N Engl J Med 295: 190-192, 1976.
47. Hinton RC, Kistler JP, Fallon JT, Friendlich AC, Fisher CM. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 40: 509-513, 1977.
48. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingam study. Neurology 28: 973-977, 1978.
49. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: The Framingam study. Stroke 14: 664-667, 1983.
50. Treseder AS, Sastry BSD, Thomas TPL, Yates MA, Pathy MSJ. Atrial fibrillation and stroke in elderly hospitalized patients. Age Aging 15: 89-92, 1986.
51. Önundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Handarson T. Chronic atrial fibrillation: epidemiologic features and 14 year follow-up. A case-control study. Eur Heart J 8: 521-527, 1987.
52. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet i: 526-529, 1987 (published erratum appears in Lancet 1987 Apr 11;1 (8537): 878).
53. Kawamoto A, Shimada K, Matubayashi K, Nishinaga M, Kimura S, Ozawa T. Factors associated with silent multiple lacunar lesions on magnetic resonance imaging in asymptomatic elderly hypertensive patients. Clin Exp Pharmacol Physiol 18: 605-610, 1991.
54. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. A clinical-pathological study of 24 cases and review of the literature. Medicine (Baltimore) 47: 337-369, 1968.
55. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 8: 212-221, 1979.
56. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23: 380-384,1988.
57. Toussirot E, Figarella-Branger D, Disdier P, Harle JR, Weiller PJ. Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology. Clin Rheum 13: 624-627, 1994.
58. Ferris EJ, Levine HL. Cerebral arteritis: classification. Radiology 109: 327-341, 1973.
59. Liem MD, Gzesh DJ, Flanders AE. MRI and angiographic diagnosis of lupus cerebral vasculitis. Neuroradiology 38: 134-136, 1996.
60. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 14 Suppl 13: 223-226, 1987.
61. Hosenpud JD, Montanaro A, Hart MV, et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 77: 286-292, 1984.
62. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42: 51-60, 1999.